FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009435198> ?p ?o ?g. }

• W2009435198 endingPage "5709" @default.
• W2009435198 startingPage "5709" @default.
• W2009435198 abstract "To investigate the protective effects of ethyl pyruvate (EP) on acute-on-chronic liver failure (ACLF) in rats.An ACLF model was established in rats, and animals were randomly divided into normal, model and EP treatment groups. The rats in EP treatment group received EP (40 mg/kg) at 3 h, 6 h, 12 h and 24 h after induction of ACLF. Serum endotoxin, high mobility group box-1 (HMGB1), alanine transaminase (ALT), tumor necrosis factor-α (TNF-α), interferon-α (IFN-γ), interleukin (IL)-10 and IL-18 levels, changes of liver histology and HMGB1 expressions in liver tissues were detected at 48 h after induction of ACLF. The effects of EP on the survival of ACLF rats were also observed.Serum levels of endotoxin (0.394 ± 0.066 EU/mL vs 0.086 ± 0.017 EU/mL, P < 0.001), HMGB1 (35.42 ± 10.86 μg/L vs 2.14 ± 0.27 μg/L, P < 0.001), ALT (8415.87 ± 3567.54 IU/L vs 38.64 ± 8.82 IU/L, P < 0.001), TNF-α (190.77 ± 12.34 ng/L vs 124.40 ± 4.12 ng/L, P < 0.001), IFN-γ (715.38 ± 86.03 ng/L vs 398.66 ± 32.91 ng/L, P < 0.001), IL-10 (6.85 ± 0.64 ng/L vs 3.49 ± 0.24 ng/L, P < 0.001) and IL-18 (85.19 ± 3.49 ng/L vs 55.38 ± 1.25 ng/L, P < 0.001) were significantly increased, and liver tissues presented severe pathological injury in the model group compared with the normal group. However, EP administration significantly improved hepatic histopathology and reduced the serum levels of endotoxin (0.155 ± 0.045 EU/mL vs 0.394 ± 0.066 EU/mL, P < 0.001) and inflammatory cytokines (11.13 ± 2.58 μg/L vs 35.42 ± 10.86 μg/L for HMGB1, 3512.86 ± 972.67 IU/L vs 8415.87 ± 3567.54 IU/L for ALT, 128.55 ± 5.76 ng/L vs 190.77 ± 12.34 ng/L for TNF-α, 438.16 ± 38.10 ng/L vs 715.38 ± 86.03 ng/L for IFN-γ, 3.55 ± 0.36 ng/L vs 6.85 ± 0.64 ng/L for IL-10, and 60.35 ± 1.63 ng/L vs 85.19 ± 3.49 ng/L for IL-18, respectively, P < 0.001), and the levels of HMGB1 in liver tissues regardless of treatment time after induction of ACLF. EP treatment at the four time points prolonged the median survival time of ACLF rats (60 h) to 162 h, 120 h, 102 h and 78 h, respectively (χ(2) = 41.17, P < 0.0001).EP administration can protect against ACLF in rats, and is a potential and novel therapeutic agent for severe liver injury." @default.
• W2009435198 created "2016-06-24" @default.
• W2009435198 creator A5011090841 @default.
• W2009435198 creator A5012014956 @default.
• W2009435198 creator A5015640756 @default.
• W2009435198 creator A5027623247 @default.
• W2009435198 creator A5032088677 @default.
• W2009435198 creator A5048951555 @default.
• W2009435198 creator A5054150116 @default.
• W2009435198 date "2012-01-01" @default.
• W2009435198 modified "2023-09-27" @default.
• W2009435198 title "Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats" @default.
• W2009435198 cites W107653729 @default.
• W2009435198 cites W1490007860 @default.
• W2009435198 cites W1555948402 @default.
• W2009435198 cites W1965764984 @default.
• W2009435198 cites W1972443740 @default.
• W2009435198 cites W1983348216 @default.
• W2009435198 cites W1983379130 @default.
• W2009435198 cites W1986626457 @default.
• W2009435198 cites W2007040683 @default.
• W2009435198 cites W2026754993 @default.
• W2009435198 cites W2027366257 @default.
• W2009435198 cites W2032025454 @default.
• W2009435198 cites W2035979188 @default.
• W2009435198 cites W2038770651 @default.
• W2009435198 cites W2039544715 @default.
• W2009435198 cites W2042988570 @default.
• W2009435198 cites W2049772445 @default.
• W2009435198 cites W2051969116 @default.
• W2009435198 cites W2058836044 @default.
• W2009435198 cites W2059217150 @default.
• W2009435198 cites W2061449596 @default.
• W2009435198 cites W2064143310 @default.
• W2009435198 cites W2069581717 @default.
• W2009435198 cites W2084109281 @default.
• W2009435198 cites W2088480444 @default.
• W2009435198 cites W2097847091 @default.
• W2009435198 cites W2101862586 @default.
• W2009435198 cites W2107277218 @default.
• W2009435198 cites W2109922371 @default.
• W2009435198 cites W2113019519 @default.
• W2009435198 cites W2135131688 @default.
• W2009435198 cites W2135374161 @default.
• W2009435198 cites W2137410252 @default.
• W2009435198 cites W2146937893 @default.
• W2009435198 cites W2150404343 @default.
• W2009435198 cites W2164714222 @default.
• W2009435198 cites W2167884444 @default.
• W2009435198 cites W2169860535 @default.
• W2009435198 cites W2171028311 @default.
• W2009435198 cites W2236970093 @default.
• W2009435198 cites W2355720708 @default.
• W2009435198 cites W2374395990 @default.
• W2009435198 cites W2466443128 @default.
• W2009435198 cites W251469064 @default.
• W2009435198 cites W41129024 @default.
• W2009435198 cites W61425884 @default.
• W2009435198 cites W2413073979 @default.
• W2009435198 doi "https://doi.org/10.3748/wjg.v18.i40.5709" @default.
• W2009435198 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3484339" @default.
• W2009435198 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23155311" @default.
• W2009435198 hasPublicationYear "2012" @default.
• W2009435198 type Work @default.
• W2009435198 sameAs 2009435198 @default.
• W2009435198 citedByCount "27" @default.
• W2009435198 countsByYear W20094351982013 @default.
• W2009435198 countsByYear W20094351982014 @default.
• W2009435198 countsByYear W20094351982015 @default.
• W2009435198 countsByYear W20094351982016 @default.
• W2009435198 countsByYear W20094351982017 @default.
• W2009435198 countsByYear W20094351982019 @default.
• W2009435198 countsByYear W20094351982020 @default.
• W2009435198 countsByYear W20094351982021 @default.
• W2009435198 countsByYear W20094351982022 @default.
• W2009435198 countsByYear W20094351982023 @default.
• W2009435198 crossrefType "journal-article" @default.
• W2009435198 hasAuthorship W2009435198A5011090841 @default.
• W2009435198 hasAuthorship W2009435198A5012014956 @default.
• W2009435198 hasAuthorship W2009435198A5015640756 @default.
• W2009435198 hasAuthorship W2009435198A5027623247 @default.
• W2009435198 hasAuthorship W2009435198A5032088677 @default.
• W2009435198 hasAuthorship W2009435198A5048951555 @default.
• W2009435198 hasAuthorship W2009435198A5054150116 @default.
• W2009435198 hasBestOaLocation W20094351981 @default.
• W2009435198 hasConcept C126322002 @default.
• W2009435198 hasConcept C134018914 @default.
• W2009435198 hasConcept C17991360 @default.
• W2009435198 hasConcept C185592680 @default.
• W2009435198 hasConcept C2776637226 @default.
• W2009435198 hasConcept C2776914184 @default.
• W2009435198 hasConcept C2778606649 @default.
• W2009435198 hasConcept C2780545709 @default.
• W2009435198 hasConcept C71924100 @default.
• W2009435198 hasConcept C90924648 @default.
• W2009435198 hasConceptScore W2009435198C126322002 @default.
• W2009435198 hasConceptScore W2009435198C134018914 @default.
• W2009435198 hasConceptScore W2009435198C17991360 @default.

• next